Clinical trial
Systems Biology Analysis of Vaccine-induced Immunity to Infectious Diseases in Healthy Participants and Participants With Cancer
NCT05787964 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Systems Biology Analysis of Vaccine-induced Immunity to Infectious Diseases in Healthy Participants and Participants With Cancer
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2022
- Completion date
- September 1, 2024
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hematologic malignancy, influenza, sars-cov-2, solid tumor